We showed that CSF ctDNA is more representative of brain tumour genomic alterations than plasma and putative actionable gene mutations and CNA (that is, EGFR, PTEN, ESR1, IDH1, ERBB2, FGFR2) can be identified. The gene discussed is FGFR2; the disease is brain neoplasm.